RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases
Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the ...
Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Robert F. Kennedy Jr.’s disclosure on Wednesday that he invested in a gene-editing biotech belies a years-long track record of ...
Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, ...
Newcells Biotech (“Newcells”), a leading drug discovery partner specializing in the development of in vitro models and bespoke assay services to improve ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Biotech analyst Brian Skorney and longtime biotech executive Daphne Zohar joined this week’s episode of “The Readout LOUD” to discuss ...
With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are ...
It’s getting more expensive to build labs and construction has fallen compared to peak activity during the pandemic. But there’s ...
Cancers of the head and neck can be treated with several drugs on the market, but for certain patients diagnosed ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.